Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kimberly L. Garrison
Observed names:
K L Garrison,
K.L. Garrison
Institution:
Gilead Sciences (United States)
Observed institutions:
University of California, San Francisco,
Gilead Sciences (United States)
OpenAlex ID:
A5007911063
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
2015
·
Edward J. Gane
, Young-Suk Lim
, et al.
·
Journal of Hepatology
·
202
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open‐label, phase 3 trial
2014
·
Masao Omata
, Shuhei Nishiguchi
, et al.
·
Journal of Viral Hepatitis
·
199
PDF
Safety and Efficacy of Ledipasvir–Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6‐11
2018
·
Karen F. Murray
, William F. Balistreri
, et al.
·
Hepatology
·
112
The Drug-Drug Interaction Potential of Antiviral Agents for the Treatment of Chronic Hepatitis C Infection
2018
·
Kimberly L. Garrison
, Polina German
, et al.
·
Drug Metabolism and Disposition
·
71
PDF
Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS
2015
·
Kimberly L. Garrison
, Selma Sahin
, et al.
·
Journal of Pharmaceutical Sciences
·
49
Ledipasvir/sofosbuvir fixed‐dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus
2016
·
Wan‐Long Chuang
, Rong‐Nan Chien
, et al.
·
Journal of Gastroenterology and Hepatology
·
27
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus
2016
·
Young-Suk Lim
, Sang Hoon Ahn
, et al.
·
Hepatology International
·
20
Discovery of Edecesertib (GS-5718): A Potent, Selective Inhibitor of IRAK4
2025
·
Stephen E. Ammann
, Jeromy J. Cottell
, et al.
·
Journal of Medicinal Chemistry
·
15
Organic Anion Transporting Polypeptide Inhibition Dramatically Increases Plasma Exposure but not Pharmacodynamic Effect nor Inferred Hepatic Intracellular Exposure of Firsocostat
2020
·
Brian J. Kirby
, Justin D. Lutz
, et al.
·
Clinical Pharmacology & Therapeutics
·
13
Pharmacokinetic Analyses of Ledipasvir/Sofosbuvir in HCV-Infected Subjects with Advanced Liver Disease And/ or following Liver Transplantation
2016
·
K.L. Garrison
, P. German
, et al.
·
Journal of Hepatology
·
3
日本の慢性遺伝子型1 Hcv感染症におけるレジパスビル/ソホスブビルの母集団薬物動態解析
2016
·
Y Ueno
, K L Garrison
, et al.
·
日本消化器がん検診学会雑誌
Show more works
View as search
Works count:
11
Citation count:
711
H-index:
9
I10-index:
9
Year
Topic
Type